Influenza chest x ray

Jump to navigation Jump to search

Influenza Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Influenza from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Influenza chest x ray On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Influenza chest x ray

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Influenza chest x ray

CDC on Influenza chest x ray

Influenza chest x ray in the news

Blogs on Influenza chest x ray

Directions to Hospitals Treating Influenza

Risk calculators and risk factors for Influenza chest x ray

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohammad Braizat, M.S. [2]


Influenza Chest X-Ray

Chest radiography (CXR) is not indicated for routine diagnosis of uncomplicated influenza. Its primary role is to evaluate for pulmonary complications — particularly influenza pneumonia and secondary bacterial pneumonia — in patients with lower respiratory tract signs (dyspnea, tachypnea, hypoxia, or clinical deterioration) or risk factors for severe disease.[1][2]

Indications for Chest Radiography

Chest radiography should be obtained when clinical findings suggest pneumonia or when there is clinical deterioration. The 2019 CHEST guideline found insufficient evidence to recommend for or against routine CXR in adults with acute cough and no validated algorithm for determining which patients warrant imaging.[3] The 2024 ACR Appropriateness Criteria support CXR in patients with acute respiratory illness who have abnormal vital signs, positive physical examination findings, or risk factors for poor outcomes.[4]

Specific triggers for imaging in influenza include:

  • Persistent or worsening fever beyond 3–5 days, or biphasic fever pattern (suggesting bacterial superinfection)[1]
  • Dyspnea, tachypnea, or hypoxia
  • Auscultatory findings (rales, rhonchi, egophony)
  • Elderly patients or those with comorbidities, in whom clinical features of pneumonia may be absent or atypical[4]

Risk Factors for Radiographic Complications

Patients with the following risk factors are at increased risk for radiographic pneumonia and warrant a lower threshold for imaging:[5][6]

  • Age extremes (≥65 years or <2 years)
  • Third-trimester pregnancy
  • Chronic pulmonary disease (COPD, asthma)
  • Cardiovascular disease (excluding hypertension alone)
  • Diabetes mellitus
  • Obesity (BMI ≥30 kg/m²)
  • Immunocompromise (including HIV, malignancy, transplant recipients, chronic steroids)
  • Functional dependency or ≥3 comorbidities

Radiographic Findings in Primary Influenza Pneumonia

In uncomplicated outpatient influenza, most patients have normal CXRs. In patients requiring hospitalization or ICU admission, the frequency of abnormalities increases substantially.[7][8]

Primary influenza pneumonia presents with diffuse bilateral infiltrates, with sputum cultures negative for bacteria.[1] Characteristic CXR findings in severe cases include:

  • Ground-glass opacities — most common finding on CT (69–89% of abnormal CTs)[8][7]
  • Consolidation — frequently coexists with GGOs (59–89% on CT)[8][7]
  • Bilateral distribution — present in 62–94% of severe cases, predominantly in mid and lower lung zones[8][7]

A lag phenomenon may occur: infiltrates may be absent on initial imaging and appear 24–72 hours later, particularly in immunocompromised patients.[1]

Diagnostic Performance of Chest Radiography

In a multicenter study of 3,423 ED patients with acute respiratory illness, CXR sensitivity for pneumonia compared to CT was 43.5% (95% CI 39.1–48.1%), with specificity 93.0% (92.0–93.9%), PPV 26.9%, and NPV 96.5%.[4][9] A negative CXR has high negative predictive value, but a significant number of pneumonias are missed by plain film.

CT is more sensitive and should be considered when:

  • There is discordance between clinical suspicion and a negative CXR
  • Complications (empyema, abscess, necrotizing pneumonia, pulmonary embolism) are suspected
  • The patient is immunocompromised[10][4]

Chest CT

CT with IV contrast is indicated when there is suspicion for empyema, abscess, or necrotizing pneumonia.[4] In immunocompromised patients, CT is preferred over CXR or lung ultrasound for evaluation of suspected pneumonia.[10]

Common CT findings include mixed GGO and consolidation, peribronchovascular distribution, lower lobe predominance, and centrilobular nodules.[11] Influenza CT features overlap substantially with COVID-19, SARS, and MERS, limiting specificity.[4]

Invasive pulmonary aspergillosis is an increasingly recognized post-influenza complication in immunocompromised and critically ill patients. Distinctive imaging findings include nodules, cavitation, and halo sign — a high-mortality diagnosis that should be considered in appropriate clinical contexts.[5]

Lung Ultrasound

Lung ultrasound (LUS) is an increasingly accepted alternative to CXR where expertise and equipment exist. Pooled LUS sensitivity for pneumonia is 92% (95% CI 88–95%) with specificity 89% (81–95%), compared to CXR specificity of 49% (40–58%).[12] A 2025 meta-analysis of 26 studies (3,454 patients) found BLUE protocol sensitivity 0.88 and dynamic air bronchograms specificity 0.96 for pneumonia diagnosis.[12] The 2025 ATS guidelines accept LUS as an alternative to CXR where expertise and equipment are available.[12]

Distinguishing Primary Influenza Pneumonia from Bacterial Superinfection

Radiographic pattern alone cannot reliably differentiate primary influenza pneumonia from bacterial coinfection; microbiologic testing remains essential.[2] However, certain features may suggest bacterial superinfection:

  • Predominant consolidation
  • Pleural effusion (uncommon in primary influenza pneumonia)[13]
  • Centrilobular nodules
  • Higher CT severity scores than primary influenza pneumonia alone[14]

The classic clinical pattern of bacterial superinfection is a biphasic illness: initial improvement followed by recurrent fever, productive cough, and new or worsening consolidation 4–14 days later.[1]

Prognostic Significance of Initial Imaging

Radiographic extent at presentation correlates with clinical severity. In H1N1 patients, involvement of four or more lung zones and bilateral peripheral opacities are associated with adverse outcomes (mechanical ventilation or death).[7] CT severity scores correlate with ICU days, mortality, peak LDH, and CRP levels.[14]

Guideline Disagreements

There are genuine disagreements among guidelines:

  • IDSA/ATS CAP guidelines (2019): Recommend radiographic confirmation for CAP diagnosis, with CT advised for uncertain or inconclusive cases[15]
  • UK NICE guidelines (2023): Restrict CXR to hospitalized patients with suspected pneumonia[12]

Common Clinical Considerations

  • CAP overdiagnosis is significant: 10–30% of patients treated for CAP do not meet diagnostic criteria.[9] Asymptomatic patients with incidental infiltrates should not be treated for CAP.
  • Pediatric considerations: Mild influenza in children most commonly shows peribronchial thickening with hyperinflation; severe cases demonstrate bilateral multifocal consolidation with ground-glass opacities similar to adults.[16]

References

  1. 1.0 1.1 1.2 1.3 1.4 Paules C, Subbarao K (2017). "Influenza". Lancet. 390 (10095): 697–708. doi:10.1016/S0140-6736(17)30129-0. PMID 29108725.
  2. 2.0 2.1 Chertow DS, Memoli MJ (2013). "Bacterial Coinfection in Influenza: A Grand Rounds Review". JAMA. 309 (3): 275–82. doi:10.1001/jama.2012.194139. PMID 23338806.
  3. Hill AT, Gold PM, El Solh AA; et al. (2019). "Adult Outpatients With Acute Cough Due to Suspected Pneumonia or Influenza: CHEST Guideline and Expert Panel Report". Chest. 155 (1): 155–167. doi:10.1016/j.chest.2018.09.016. PMID 30317018.
  4. 4.0 4.1 4.2 4.3 4.4 4.5 Batra K, Walker CM, Little BP; et al. (2025). "ACR Appropriateness Criteria® Acute Respiratory Illness in Immunocompetent Patients: 2024 Update". J Am Coll Radiol. 22 (5S): S14–S35. doi:10.1016/j.jacr.2025.02.014. PMID 40070492 Check |pmid= value (help).
  5. 5.0 5.1 Kumar V (2022). "Influenza". Lancet. 399 (10325): 725–738. doi:10.1016/S0140-6736(21)02430-8. PMID 34953525 Check |pmid= value (help).
  6. Valencia C; et al. (2020). "Risk factors for severe influenza and influenza pneumonia". Clin Infect Dis. PMID 33428769 Check |pmid= value (help).
  7. 7.0 7.1 7.2 7.3 7.4 Aviram G, Bar-Shai A, Sosna J; et al. (2010). "H1N1 Influenza: Initial Chest Radiographic Findings in Helping Predict Patient Outcome". Radiology. 255 (1): 252–9. doi:10.1148/radiol.10092240. PMID 20173283.
  8. 8.0 8.1 8.2 8.3 Rohani P, Jude CM, Chan K, Barot N, Kamangar N (2016). "Chest Radiological Findings of Patients With Severe H1N1 Pneumonia Requiring Intensive Care". J Intensive Care Med. 31 (1): 51–60. doi:10.1177/0885066614538753. PMID 25422345.
  9. 9.0 9.1 Self WH; et al. (2018). "Diagnostic accuracy of chest radiography for pneumonia in the emergency department". Ann Emerg Med. PMID 29355038.
  10. 10.0 10.1 Aliberti S, Dela Cruz CS, Amati F, Sotgiu G, Restrepo MI (2021). "Community-Acquired Pneumonia". Lancet. 398 (10303): 906–919. doi:10.1016/S0140-6736(21)00630-9. PMID 34419249 Check |pmid= value (help).
  11. Onigbinde SO, Ojo AS, Fleary L, Hage R (2020). "Chest Computed Tomography Findings in COVID‐19 and Influenza: A Narrative Review". Biomed Res Int. 2020: 6928368. doi:10.1155/2020/6928368. PMID 33354345 Check |pmid= value (help).
  12. 12.0 12.1 12.2 12.3 Reyes LF, Conway Morris A, Serrano-Mayorga C; et al. (2025). "Community-Acquired Pneumonia". Lancet. 406 (10517): 2371–2388. doi:10.1016/S0140-6736(25)01493-X. PMID 40675194 Check |pmid= value (help).
  13. Song JY, Cheong HJ, Heo JY; et al. (2011). "Clinical, laboratory and radiologic characteristics of 2009 pandemic influenza A/H1N1 pneumonia". Influenza Other Respir Viruses. 5 (6): e535–43. doi:10.1111/j.1750-2659.2011.00269.x. PMID 21631695.
  14. 14.0 14.1 Kang VJ, Huang YS, Chen MC; et al. (2024). "CT Findings of 144 in-Hospital Patients With Influenza Pneumonia". J Formos Med Assoc. 123 (3): 381–389. doi:10.1016/j.jfma.2023.08.022. PMID 37716589 Check |pmid= value (help).
  15. Metlay JP, Waterer GW, Long AC; et al. (2019). "Diagnosis and Treatment of Adults with Community-acquired Pneumonia". Am J Respir Crit Care Med. 200 (7): e45–e67. doi:10.1164/rccm.201908-1581ST. PMID 31573350.
  16. Lee EY, McAdam AJ, Chaudry G; et al. (2010). "Swine-Origin Influenza a (H1N1) Viral Infection in Children". Radiology. 254 (3): 934–41. doi:10.1148/radiol.09092083. PMID 20173119.